BDR Pharmaceuticals Sues FDA Over Voquezna Application, Impacting PHAT Stock
gurufocus.com · 2026-10-23
On October 23, 2026, Phathom Pharmaceuticals Inc (PHAT) faces legal uncertainty as BDR Pharmaceuticals initiates a lawsuit challenging the FDA's refusal to acce
Read the full story at gurufocus.com →
Is PHAT undervalued? See TickrTrends' fair value analysis →